I-Dengue NS1 Antigen, IgM/IgG Antibody Dual
Igama lemveliso
Ikhithi yokuFumanisa ii-Antigen ezimbini ze-HWTS-FE031-Dengue NS1, i-IgM/IgG (i-Immunochromatography)
Isatifikethi
CE
I-Epidemiology
Umkhuhlane weDengue sisifo esosulelayo esibangelwa kukulunywa ziingcongconi ezibhinqileyo ezithwala intsholongwane yeDengue (i-DENV), esinokusasazeka ngokukhawuleza, ukwanda kwaso, ukusasazeka ngokubanzi, kunye nokufa okuphezulu kwiimeko ezinzima..
Abantu abamalunga nezigidi ezingama-390 kwihlabathi liphela bosulelwa yi-dengue fever minyaka le, apho abantu abazizigidi ezingama-96 bachatshazelwa sesi sifo kumazwe angaphezu kwe-120, uninzi lwabo lukwiAfrika, eMelika, eMzantsi-mpuma Asia nakwiNtshona yePasifiki. Njengoko ukufudumala kwehlabathi kusanda, i-dengue fever ngoku isasazeka kwiindawo ezishushu nezibandayo nakwiindawo eziphakamileyo, kwaye ukuxhaphaka kwe-serotypes kuyatshintsha. Kwiminyaka yakutshanje, imeko yobhubhane we-dengue fever imbi kakhulu kummandla waseMzantsi Pasifiki, eAfrika, eMzantsi Melika, kumazantsi e-Asia nakuMzantsi-mpuma Asia, kwaye ibonisa amazinga ahlukeneyo okwanda kohlobo lwe-serotype yayo yosulelo, indawo yokuphakama, amaxesha onyaka, izinga lokufa kunye nenani losulelo.
Idatha esemthethweni ye-WHO ngo-Agasti 2019 ibonise ukuba bekukho malunga nama-200,000 amatyala e-dengue fever kunye nokufa kwabantu abangama-958 ePhilippines. IMalaysia ibiqokelele amatyala e-dengue angaphezu kwama-85,000 phakathi ku-Agasti 2019, ngelixa iVietnam ibiqokelele amatyala angama-88,000. Xa kuthelekiswa nexesha elifanayo ngo-2018, inani linyuke ngokuphindwe kabini kumazwe omabini. I-WHO ithathe i-dengue fever njengengxaki enkulu yempilo yoluntu.
Le mveliso yikhithi yokubona ngokukhawuleza, kwindawo leyo kwaye ichanekileyo ye-antigen ye-dengue virus NS1 kunye ne-antibody ye-IgM/IgG. I-antibody ethile ye-IgM ibonisa ukuba kukho usulelo lwakutshanje, kodwa uvavanyo lwe-IgM olungalunganga alubonisi ukuba umzimba awosuleleki. Kwakhona kuyimfuneko ukufumanisa ii-antibodies ezithile ze-IgG ezinesiqingatha sobomi esingaphezulu kunye nomxholo ophezulu ukuqinisekisa ukuxilongwa. Ukongeza, emva kokuba umzimba usuleleke, i-antigen ye-NS1 ivela kuqala, ngoko ke ukufunyanwa ngaxeshanye kwe-antigen ye-dengue virus NS1 kunye nee-antibodies ezithile ze-IgM kunye ne-IgG zinokuchonga ngempumelelo impendulo yomzimba kwi-pathogen ethile, kwaye le kit yokubona i-antigen-antibody edibeneyo inokwenza ukuxilongwa kwangoko kunye nokuhlolwa kwangoko kwinqanaba lokuqala losulelo lwe-dengue, usulelo oluphambili kunye nosulelo lwesibini okanye oluninzi lwe-dengue, inciphise ixesha lewindow kwaye iphucule izinga lokufunyanwa.
Iiparameters zobugcisa
| Indawo ekujoliswe kuyo | Ii-antigen ze-NS1 zegciwane le-dengue, i-IgM kunye ne-IgG |
| Ubushushu bokugcina | 4℃ -30℃ |
| Uhlobo lwesampulu | I-serum yomntu, i-plasma, igazi lemithambo yegazi kunye negazi elisencamini yomunwe |
| Beka ubomi kwishelufa | Iinyanga ezili-12 |
| Izixhobo ezincedisayo | Ayifuneki |
| Izinto ezisetyenziswayo ezongezelelweyo | Ayifuneki |
| Ixesha lokufunyaniswa | imizuzu eli-15-20 |
| Ukuchaneka | Yenza uvavanyo lwe-cross-reactivity kunye ne-Japanese encephalitis virus, i-forest encephalitis virus, i-hemorrhagic fever ene-thrombocytopenia syndrome, i-Xinjiang hemorrhagic fever, i-hantavirus, i-hepatitis C virus, i-influenza A virus, i-influenza B virus, akukho cross-reactivity ifunyenweyo. |
Ukuhamba komsebenzi
●Igazi lemithambo yegazi (iSerum, iPlasma, okanye igazi elipheleleyo)
●Igazi elisezinwebeni
●Funda isiphumo (imizuzu eli-15-20)
